[HTML] nature.comFull View

[HTML][HTML] Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

J Cantley, X Ye, E Rousseau, T Januario… - Nature …, 2022 - nature.com
Abstract The mammalian SWItch/Sucrose Non-Fermentable (SWI/SNF) helicase SMARCA4
is frequently mutated in cancer and inactivation results in a cellular dependence on its …
被引用次数：54 相关文章

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

J Cantley, X Ye, E Rousseau, T Januario… - Nature …, 2022 - ideas.repec.org
The mammalian SWItch/Sucrose Non-Fermentable (SWI/SNF) helicase SMARCA4 is
frequently mutated in cancer and inactivation results in a cellular dependence on its paralog …

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers.

J Cantley, X Ye, E Rousseau, T Januario… - Nature …, 2022 - europepmc.org
The mammalian SWItch/Sucrose Non-Fermentable (SWI/SNF) helicase SMARCA4 is
frequently mutated in cancer and inactivation results in a cellular dependence on its paralog …
[HTML] nih.gov

[HTML][HTML] Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

J Cantley, X Ye, E Rousseau, T Januario… - Nature …, 2022 - ncbi.nlm.nih.gov
Abstract The mammalian SWItch/Sucrose Non-Fermentable (SWI/SNF) helicase SMARCA4
is frequently mutated in cancer and inactivation results in a cellular dependence on its …

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

J Cantley, X Ye, E Rousseau, T Januario… - Nature …, 2022 - econpapers.repec.org
Abstract The mammalian SWItch/Sucrose Non-Fermentable (SWI/SNF) helicase SMARCA4
is frequently mutated in cancer and inactivation results in a cellular dependence on its …
[PDF] archive.org

[PDF][PDF] Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

R Yauch, J Cantley, LLC Arvinas, X Ye, E Rousseau… - scholar.archive.org
The mammalian SWI/SNF helicase SMARCA4 is frequently mutated in cancer and
inactivation results in a cellular dependence on its paralog, SMARCA2, thus making …

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

R Yauch, J Cantley, X Ye, E Rousseau, T Januario… - 2022 - researchsquare.com
The mammalian SWI/SNF helicase SMARCA4 is frequently mutated in cancer and
inactivation results in a cellular dependence on its paralog, SMARCA2, thus making …

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

J Cantley, X Ye, E Rousseau… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
The mammalian SWItch/Sucrose Non-Fermentable (SWI/SNF) helicase SMARCA4 is
frequently mutated in cancer and inactivation results in a cellular dependence on its paralog …

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers.

J Cantley, X Ye, E Rousseau, T Januario… - Nature …, 2022 - search.ebscohost.com
Abstract The mammalian SWItch/Sucrose Non-Fermentable (SWI/SNF) helicase SMARCA4
is frequently mutated in cancer and inactivation results in a cellular dependence on its …

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers

J Cantley, X Ye, E Rousseau, T Januario… - Nature …, 2022 - ui.adsabs.harvard.edu
Abstract The mammalian SWItch/Sucrose Non-Fermentable (SWI/SNF) helicase SMARCA4
is frequently mutated in cancer and inactivation results in a cellular dependence on its …